Jacob E. Berchuck, MD, discusses how a new epigenomic platform may influence the accessibility of PSMA-based therapies, especially for patients who may not have easy access to PSMA PET scans.
Prostate cancer is one of those things most men don’t think about until it hits close to home. But it’s common, affecting millions—and early detection can save lives. The cancer itself can be sneaky, ...